@LTxJournal We can all capitalize on so many missed opportunities on improve the health and longevity of our transplant patients with currently available drugs at our finger tips!
Some opportunities shouldn’t be missed — like reading our new manuscript on missed opportunities to improve long-term liver allograft health. Guided by Dr. O’Leary’s mentorship, this one’s worth a look! 🍎🩺
Your team could be the next champions of the #TLM25 Academic Debate! Submit your application by Aug. 29 and make an impact on this year’s topic: Use of #machineperfusion and Living Donor Grafts. https://t.co/r6MYi2zLsD #livertransplant
Now we have RCT evidence for tapered prednisolone dose for alcohol associated hepatitis - this significantly reduces infection risk 👏⭐️
📸: @AnandVKulkarni2@AmJGastro
https://t.co/ujOostfQMp
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
@JHepatology
https://t.co/aeG5tU8gqt
🔥Get the new guideline for HCC
👉Up to date, very granular recommendations
@EASLedu@myESMO@ILCAnews#livertwitter
@LorrindaD@ebtapper I learned during my residency to introduce the team as SUPPORTIVE and palliative care team, rather than just palliative care team and referring to them as experts in management of symptoms rather than just saying end of life care or hospice.
Chronic liver disease is 🇺🇸 9th leading cause of ☠️, claiming >70K lives a year.
Early detection is ‼️ crucial to curb this impact - esp important pandemic use of🍸🍻🍷.
Hats off to @hazelreporting for the courage to share the story. 🙏💪 https://t.co/ZaQEn3MMz1
😴 Sleepy time activities are encouraged on this rotation!
Watch the latest video in our partnership with @DGlaucomflecken as he explains the results of the SURMOUNT-OSA trial during sleep medicine rounds: https://t.co/bzt6pnm2oS
It is no surprise to me that UTSW won the academic debate at #TLM2024 🥇 Lots of practice and late nights for these two really paid off! Winners of the Liver Cup 🏆 Congratulations! @AminFa91@dr_ash_arvind@docamitgs